Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

NCT03522441 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1125

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Clindamycin 1% Gel
DRUG: Placebo

Sponsor

Akorn, Inc.